Skip to content
Subscriber Only
Technology
Prognosis

Moderna Backtracks to Open Covid Vaccine Trial to Those With HIV

  • Advocates pressured Moderna to expand criteria in recent weeks
  • Pfizer also lobbied to open vaccine trials to those with HIV
Chemicals sit inside a refrigerator at the Moderna Therapeutics Inc. lab in Cambridge, Mass.

Chemicals sit inside a refrigerator at the Moderna Therapeutics Inc. lab in Cambridge, Mass.

Photographer: Adam Glanzman/Bloomberg

After pressure from advocates in recent weeks, Moderna Inc. will now allow individuals living with HIV to be part of a late-stage clinical trial of its Covid-19 vaccine candidate.

Moderna had previously said it would exclude people with HIV from the trial.